Effects of chronic hyperandrogenism and/or administered central nervous system insulin on ovarian manifestation and gonadotropin and steroid secretion
- PMID: 15831308
- DOI: 10.1016/j.fertnstert.2004.12.028
Effects of chronic hyperandrogenism and/or administered central nervous system insulin on ovarian manifestation and gonadotropin and steroid secretion
Abstract
Objective: Polycystic ovarian syndrome is characterized by hyperandrogenism and insulin resistance. We studied the effects of central hyperinsulinemia and peripheral hyperandrogenism on gonadotropin secretion, steroid secretion, and ovarian histology in female rats.
Design: Experimental in vivo animal study.
Setting: University research center.
Animal(s): 250-300 g female Wistar rats.
Intervention(s): Insertion of testosterone pellets and/or administration of intracerebroventricular (ICV) insulin.
Main outcome measure(s): Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels before and after GnRH administration; testosterone, insulin, and glucose levels; and ovarian histology.
Result(s): Compared with control, rats with testosterone implant had a lower LH and higher FSH while rats with testosterone plus insulin had a higher FSH. Intracerebroventricular (ICV) insulin alone increased LH in response to GnRH. Ovarian histology indicated that testosterone-implanted rats had larger ovaries and an increased number of cystic follicles >50 microm as well as substantial theca enlargement. The administration of testosterone did not alter serum insulin, and ICV insulin did not increase testosterone levels.
Conclusion(s): We suggest that ICV insulin acts either directly or indirectly to increase the LH responsiveness to GnRH. ICV insulin arrested the maturation of follicles leading to an increase in the number of small follicles. Peripheral androgens stimulated theca enlargement with cystic follicles. The combination of ICV insulin and peripheral androgens attenuated ovarian histologic changes and gonadotropin secretion. Thus, central hyperinsulinemia and peripheral hyperandrogenism may play a role in gonadotropin secretion as well as ovarian morphology.
Similar articles
-
[Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats].Zhonghua Fu Chan Ke Za Zhi. 2007 Aug;42(8):546-50. Zhonghua Fu Chan Ke Za Zhi. 2007. PMID: 17983495 Chinese.
-
Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology.Fertil Steril. 2007 Apr;87(4):870-5. doi: 10.1016/j.fertnstert.2006.08.096. Epub 2007 Jan 16. Fertil Steril. 2007. PMID: 17224152
-
Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.Semin Reprod Med. 2007 Sep;25(5):352-9. doi: 10.1055/s-2007-984741. Semin Reprod Med. 2007. PMID: 17710731 Review.
-
Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.Fertil Steril. 2005 May;83(5):1466-72. doi: 10.1016/j.fertnstert.2004.11.046. Fertil Steril. 2005. PMID: 15866586
-
The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest.Hum Reprod Update. 2004 Mar-Apr;10(2):107-17. doi: 10.1093/humupd/dmh010. Hum Reprod Update. 2004. PMID: 15073141 Review.
Cited by
-
Association between The Number of Retrieved Mature Oocytes and Insulin Resistance or Sensitivity in Infertile Women with Polycystic Ovary Syndrome.Int J Fertil Steril. 2019 Jan;12(4):310-315. doi: 10.22074/ijfs.2019.5422. Epub 2018 Oct 2. Int J Fertil Steril. 2019. PMID: 30291692 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical